New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Pozen (POZN)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
POZN
»
Topics
»
CONTACTS:
This excerpt taken from the
POZN 8-K
filed Mar 7, 2007.
CONTACTS:
Bill Hodges
Fran Barsky
Chief Financial Officer
Director, Investor Relations
919-913-1030
919-913-1044
This excerpt taken from the
POZN 8-K
filed Mar 1, 2006.
CONTACTS:
Bill Hodges
Fran Barsky
Chief Financial Officer
Director, Investor Relations
919-913-1030
919-913-1044
This excerpt taken from the
POZN 8-K
filed Jul 28, 2005.
CONTACTS:
Bill Hodges
Fran Barsky
Chief Financial Officer
Director, Investor Relations
919-913-1030
919-913-1044
EXCERPTS ON THIS PAGE:
8-K
Mar 7, 2007
8-K
Mar 1, 2006
8-K
Jul 28, 2005
RELATED TOPICS for POZN:
Chapel Hill 2007 Pozen Inc Nasdaq Pozn Today
Chapel Hill 2006 Pozen Inc Nasdaq Pozn Today
Trexima Nda Track 2005 Submission
VIEW MORE
"CONTACTS:" elsewhere:
Allos Therapeutics (ALTH)
ArQule (ARQL)
Cubist Pharmaceuticals (CBST)
Isis Pharmaceuticals (ISIS)
Ligand Pharmaceuticals (LGND)
NitroMed (NTMD)
Pharmacyclics (PCYC)
PDL BioPharma (PDLI)
Astex Pharmaceuticals, Inc (SUPG)
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour